Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee-Reference-Cited by-同舟云学术

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

Published:2022-12 Issue:12 Volume:17 Page:1335-1354
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Mino-Kenudson Mari,Schalper Kurt,Cooper Wendy,Dacic Sanja,Hirsch Fred R.,Jain Deepali,Lopez-Rios Fernando,Tsao Ming Sound,Yatabe Yasushi,Beasley Mary Beth,Yu Hui,Sholl Lynette M.,Brambilla Elizabeth,Chou Teh-Ying,Connolly Casey,Wistuba Ignacio,Kerr Keith M.,Lantuejoul Sylvie

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference164 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. First-line immunotherapy for non-small-cell lung cancer;Reck;J Clin Oncol,2022

3. Sintilimab for the treatment of non-small cell lung cancer;Zhang;Biomark Res,2022

4. PD-L1 testing for lung cancer in 2019: perspective from the IASLC pathology committee;Lantuejoul;J Thorac Oncol,2020

5. The promises and challenges of tumor mutation burden as an immunotherapy biomarker: a perspective from the International Association for the Study of Lung Cancer Pathology Committee;Sholl;J Thorac Oncol,2020

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids;Respiratory Investigation;2024-11

2. Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study;Neoplasia;2024-11

3. Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy;Lung Cancer;2024-09

4. Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer;2024-08-28

5. Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors;Journal of Thoracic Imaging;2024-08-27